TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Generic Pharmaceuticals Wave 13

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published3
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS National Generic Pharmaceuticals Wave 13". Published status: complete. Published value: Value not published. 3 published lots. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46Bids / Report
1.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published14 Jan 2022, 10:31 GMT
Last source update14 Jan 2022, 10:31 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-02be28
What is being bought
Potential periods of call-offs under the framework agreement:<br/><br/>Transition (Everolimus)<br/>CESW: 1 March 2022 – 30 September 2023 (19 months)<br/>LSNE: 1 March 2022 – 31 January 2023 (11 months)<br/>NWLN: 1 March 2022 – 31 January 2023 (11 months)<br/><br/>Oral Products plus non-parenterals<br/>All Regions: 1 March 2022 - 31 May 2024 (27 months)<br/><br/>Hospital Only Products<br/>CESW: 1 February 2022 – 30 September 2023 (20 months)<br/>LSNE: 1 February 2022 – 31 May 2024 (28 months)<br/>NWLN: 1 February 2022 – 31 January 2023 (12 months)
What changed
From the official release history
  1. tender value changed
    14 Jan 2022, 10:31 GMT
  2. Status changed to complete
    14 Jan 2022, 10:31 GMT
  3. Official notice release published
    14 Jan 2022, 10:31 GMT
  4. Submission deadline changed to published date
    14 Jan 2022, 10:31 GMT
  5. Published value updated to £1,637,875,080
    21 Jun 2021, 11:23 BST
  6. Status changed to active
    21 Jun 2021, 11:23 BST
  7. Official notice release published
    21 Jun 2021, 11:23 BST
  8. Submission deadline changed to 26 Jul 2021, 13:00 BST
    21 Jun 2021, 11:23 BST
  9. Buyer information updated
    21 Jun 2021, 11:23 BST
Lots and requirements (3)
Published by the contracting authority
  • Lot 1 · #1
    Lot 1 - CM/PHG/17/5532/00 Transition (Everolimus)
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Generic Pharmaceuticals Wave 13<br/>Offer reference number: CM/PHG/17/5532<br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.<br/><br/>Potential periods of call-offs under the framework agreement:<br/><br/>Transition (Everolimus)<br/>CESW: 1 March 2022 – 30 September 2023 (19 months)<br/>LSNE: 1 March 2022 – 31 January 2023 (11 months)<br/>NWLN: 1 March 2022 – 31 January 2023 (11 months)<br/><br/>Oral Products plus non-parenterals<br/>All Regions: 1 March 2022 - 31 May 2024 (27 months)<br/><br/>Hospital Only Products<br/>CESW: 1 February 2022 – 30 September 2023 (20 months)<br/>LSNE: 1 February 2022 – 31 May 2024 (28 months)<br/>NWLN: 1 February 2022 – 31 January 2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 2 · #2
    Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Generic Pharmaceuticals Wave 13<br/>Offer reference number: CM/PHG/17/5532<br/>Period of framework agreement:The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.<br/><br/>Potential periods of call-offs under the framework agreement:<br/><br/>Transition (Everolimus)<br/>CESW: 1 March 2022 – 30 September 2023 (19 months)<br/>LSNE: 1 March 2022 – 31 January 2023 (11 months)<br/>NWLN: 1 March 2022 – 31 January 2023 (11 months)<br/><br/>Oral Products plus non-parenterals<br/>All Regions: 1 March 2022 - 31 May 2024 (27 months)<br/><br/>Hospital Only Products<br/>CESW: 1 February 2022 – 30 September 2023 (20 months)<br/>LSNE: 1 February 2022 – 31 May 2024 (28 months)<br/>NWLN: 1 February 2022 – 31 January 2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
  • Lot 3 · #3
    Lot 3 - CM/PHG/17/5532/02 Hospital Only Products
    cancelled
    Published valueNot published
    Invitation to offer for NHS National Generic Pharmaceuticals Wave 13<br/>Offer reference number: CM/PHG/17/5532<br/>Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority’s sole discretion) for a period or periods up to a total of 48 months.<br/><br/>Potential periods of call-offs under the framework agreement:<br/><br/>Transition (Everolimus)<br/>CESW: 1 March 2022 – 30 September 2023 (19 months)<br/>LSNE: 1 March 2022 – 31 January 2023 (11 months)<br/>NWLN: 1 March 2022 – 31 January 2023 (11 months)<br/><br/>Oral Products plus non-parenterals<br/>All Regions: 1 March 2022 - 31 May 2024 (27 months)<br/><br/>Hospital Only Products<br/>CESW: 1 February 2022 – 30 September 2023 (20 months)<br/>LSNE: 1 February 2022 – 31 May 2024 (28 months)<br/>NWLN: 1 February 2022 – 31 January 2023 (12 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    14 Jan 2022, 10:31 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Award active
    Not published · Not published
  13. Award active
    Not published · Not published
  14. Award active
    Not published · Not published
  15. Award active
    Not published · Not published
  16. Award active
    Not published · Not published
  17. Award active
    Not published · Not published
  18. Award active
    Not published · Not published
  19. Award active
    Not published · Not published
  20. Award active
    Not published · Not published
  21. Award active
    Not published · Not published
  22. Award active
    Not published · Not published
  23. Award active
    Not published · Not published
  24. Award active
    Not published · Not published
  25. Award active
    Not published · Not published
  26. Award active
    Not published · Not published
  27. Award active
    Not published · Not published
  28. Award active
    Not published · Not published
  29. Award active
    Not published · Not published
  30. Award active
    Not published · Not published
  31. Award active
    Not published · Not published
  32. Award active
    Not published · Not published
  33. Award active
    Not published · Not published
  34. Award active
    Not published · Not published
  35. Award active
    Not published · Not published
  36. Award active
    Not published · Not published
  37. Award active
    Not published · Not published
  38. Award active
    Not published · Not published
  39. Award active
    Not published · Not published
  40. Award active
    Not published · Not published
  41. Award active
    Not published · Not published
  42. Award active
    Not published · Not published
  43. Award active
    Not published · Not published
  44. Award active
    Not published · Not published
  45. Award active
    Not published · Not published
  46. Award active
    Not published · Not published
  47. Award active
    Not published · Not published
  48. Award active
    Not published · Not published
  49. Award active
    Not published · Not published
  50. Award active
    Not published · Not published
  51. Award active
    Not published · Not published
  52. Contract active
    Signed 30 Dec 2021, 00:00 GMT · £1
  53. Contract active
    Signed 30 Dec 2021, 00:00 GMT · £1
  54. Contract active
    Signed 30 Dec 2021, 00:00 GMT · £1
  55. Contract active
    Signed 30 Dec 2021, 00:00 GMT · £1
  56. Contract active
    Signed 30 Dec 2021, 00:00 GMT · £1
  57. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  58. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  59. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  60. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  61. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  62. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  63. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  64. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  65. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  66. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  67. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  68. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  69. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  70. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  71. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  72. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  73. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  74. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  75. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  76. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  77. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  78. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  79. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  80. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  81. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  82. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  83. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  84. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  85. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  86. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  87. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  88. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  89. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  90. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  91. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  92. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  93. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  94. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  95. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  96. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  97. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  98. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  99. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  100. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
  101. Contract active
    Signed 30 Nov 2021, 00:00 GMT · £1
Commercial outcome and competition
Awards
Martindale Pharma
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Accord-UK Ltd
Not published · Not published · active
GlaxoSmithKline UK Limited
Not published · Not published · active
Syri Limited (T/A Thame Laboratories)
Not published · Not published · active
medac Pharma LLP
Not published · Not published · active
Martindale Pharma
Not published · Not published · active
Rosemont Pharmaceuticals Limited
Not published · Not published · active
Mercury Pharmaceuticals Limited
Not published · Not published · active
Selective Supplies Ltd.
Not published · Not published · active
Consilient Health Ltd
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Glenmark Pharmaceuticals Europe Limited
Not published · Not published · active
Healthcare Pharma Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Mylan
Not published · Not published · active
Macleods Pharma UK Limited
Not published · Not published · active
Wockhardt UK Limited
Not published · Not published · active
Dr Falk Pharma UK Ltd
Not published · Not published · active
Desitin Pharma Ltd
Not published · Not published · active
Torrent Pharma UK Ltd
Not published · Not published · active
Fontus Health Ltd
Not published · Not published · active
Aspire Pharma Limited
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Amarox Limited
Not published · Not published · active
AOP Orphan Ltd
Not published · Not published · active
Ranbaxy UK
Not published · Not published · active
Arcadia Pharma Ltd T/A Arcadia Medical
Not published · Not published · active
Derma UK
Not published · Not published · active
Zista Pharma Ltd
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Aspen Pharmacare UK Limited
Not published · Not published · active
Manx Healthcare Ltd
Not published · Not published · active
Colonis Pharma Ltd
Not published · Not published · active
Roche Products Ltd
Not published · Not published · active
Profile Pharma Ltd
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
Organon Pharmaceuticals UK Ltd
Not published · Not published · active
Day Lewis Medical Ltd
Not published · Not published · active
LogixX Pharma Ltd
Not published · Not published · active
Lundbeck Limited
Not published · Not published · active
Napp Pharmaceuticals Ltd
Not published · Not published · active
Bayer Ltd
Not published · Not published · active
Morningside Pharmaeuticals
Not published · Not published · active
Dexcel Pharma Ltd
Not published · Not published · active
CST Pharma Limited
Not published · Not published · active
Cipla (EU) Ltd
Not published · Not published · active
Relonchem Ltd
Not published · Not published · active
Contracts
Lot 1 - CM/PHG/17/5532/00 Transition (Everolimus)
£1 · signed 30 Dec 2021, 00:00 GMT · active
Lot 1 - CM/PHG/17/5532/00 Transition (Everolimus)
£1 · signed 30 Dec 2021, 00:00 GMT · active
Lot 1 - CM/PHG/17/5532/00 Transition (Everolimus)
£1 · signed 30 Dec 2021, 00:00 GMT · active
Lot 1 - CM/PHG/17/5532/00 Transition (Everolimus)
£1 · signed 30 Dec 2021, 00:00 GMT · active
Lot 1 - CM/PHG/17/5532/00 Transition (Everolimus)
£1 · signed 30 Dec 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Lot 2 - CM/PHG/17/5532/01 Oral Products plus non-parenterals
£1 · signed 30 Nov 2021, 00:00 GMT · active
Bid statistics
bids: 7 (lot 1)
bids: 7 (lot 1)
bids: 7 (lot 1)
bids: 7 (lot 1)
bids: 7 (lot 1)
electronicBids: 7 (lot 1)
electronicBids: 7 (lot 1)
electronicBids: 7 (lot 1)
electronicBids: 7 (lot 1)
electronicBids: 7 (lot 1)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
bids: 124 (lot 2)
Buyer and organisations in this procedure
Showing primary 50 of 133 published organisations

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authority GB-FTS-2505
View buyer profile

  • The NHS Commissioning Board (operating under the name of NHS England)
    buyer
    centralPurchasingBody

    2nd Floor, Rutland House, Runcorn, UK, WA7 2ES
    gemma.tomlinson1@nhs.net

  • ACIUM LTD
    supplier

    Stevenage, UK

  • AOP Orphan Ltd
    supplier

    Weybridge, UK

  • Accord-UK Ltd
    supplier

    Barnstaple, UK

  • Aguettant Ltd
    supplier

    Bristol, UK

  • Alissa Healthcare Research Limited
    supplier

    Fareham, UK

  • Allergan
    supplier

    Marlow, UK

  • Alliance Pharmaceuticals Limited
    supplier

    Chippenham, UK

  • Altan Pharma Ltd
    supplier

    Dublin, IE

  • Alturix
    supplier

    Milton Keynes, UK

  • Amarox Limited
    supplier

    Harrow, UK

  • Arcadia Pharma Ltd T/A Arcadia Medical
    supplier

    Fforestfach, UK

  • Aristo Pharma Limited
    supplier

    Ely, UK

  • Ascend Laboratories UK Ltd
    supplier

    London, UK

  • Aspen Pharmacare UK Limited
    supplier

    Maidenhead, UK

  • Aspire Pharma Limited
    supplier

    Godalming, UK

  • Atnahs Pharma UK Ltd
    supplier

    London, UK

  • Aventis Pharma ltd t/a Sanofi
    supplier

    Reading, UK

  • B. Braun Medical Limited
    supplier

    Sheffield, UK

  • Baxter Healthcare Ltd
    supplier

    Thetford, UK

  • Bayer Ltd
    supplier

    Reading, UK

  • Beaumont Pharma Ltd
    supplier

    Burnley, UK

  • Bowmed Ibisqus Limited
    supplier

    Manchester, UK

  • Bristol Laboratories Limited
    supplier

    Berkhamsted, UK

  • Brown and Burk UK Ltd
    supplier

    Hounslow, UK

  • CST Pharma Limited
    supplier

    Walsall, UK

  • Chiesi Limited
    supplier

    Manchester, UK

  • Cipla (EU) Ltd
    supplier

    Addlestone, UK

  • Clydesdale Pharma ltd
    supplier

    Tadley, UK

  • Colonis Pharma Ltd
    supplier

    London, UK

  • Consilient Health Ltd
    supplier

    Richmond upon Thames, UK

  • Correvio GmbH
    supplier

    Bielefeld, DE

  • Crescent Pharma Ltd
    supplier

    Basingstoke, UK

  • Day Lewis Medical Ltd
    supplier

    Croydon, UK

  • Derma UK
    supplier

    Ouseburn, UK

  • Desitin Pharma Ltd
    supplier

    Woking, UK

  • Dexcel Pharma Ltd
    supplier

    Daventry, UK

  • Dr Falk Pharma UK Ltd
    supplier

    Bourne End, UK

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    Beverley, UK

  • Drugsrus Ltd
    supplier

    Northwood, UK

  • Euro-Link Pharma Ltd
    supplier

    Luton, UK

  • FLYNN PHARMA LTD
    supplier

    Dublin, IE

  • Ferndale Pharmaceuticals Ltd
    supplier

    Wetherby, UK

  • Ferring Pharmaceuticals Ltd
    supplier

    West Drayton, UK

  • Flexipharm Austrading Limited
    supplier

    Bourne End, UK

  • Focus Pharmaceuticals Ltd
    supplier

    London, UK

  • Fontus Health Ltd
    supplier

    Walsall, UK

  • Fresenius Kabi Limited
    supplier

    Runcorn, UK

  • Galen Limited
    supplier

    Co Armagh, UK

  • GlaxoSmithKline UK Limited
    supplier

    London, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published